ClinicalTrials.gg
CompletedNCT02137785Updated Sep 16, 2015Results posted

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

A Phase 3 interventional study of Aminolevulinic Acid (ALA) and Topical Solution Vehicle in Actinic Keratosis, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 13 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-09-16.

Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
269
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.

Enrollment
3rd of 29
269 · median 32
Started
2014
with 3 others
Phase 3
5 of 29
none open now
Registered
8th of 29
by date
Lead sponsor
9 of 29
DUSA Pharmaceuticals, Inc.

Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 3rd largest by enrollment, is one of 4 that started in 2014, is one of 5 in phase 3, and was the 8th registered.

Keratosis, Actinic

343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.

Browse Keratosis, Actinic studies →

Open to participants now

1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About Aminolevulinic Acid

Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, or all of them as a file.
02

Study summary

The purpose of this study is to determine if Levulan Photodynamic Therapy (PDT) is safe and effective in the treatment of actinic keratoses on the upper arms and hands

03

Conditions studied

  • Actinic Keratosis

Browse trials for

Keywords

  • Actinic Keratosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Four to fifteen Grade 1/2 actinic keratosis lesions (AKs) on one upper extremity

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • grade 3 and/or atypical >1cm AKs within Treatment Area
  • history of cutaneous photosensitization, porphyria, to porphyrins or photodermatosis
  • lesions suspicious for skin cancer (skin cancer not ruled out by ) or untreated skin cancers within the Treatment Area
  • skin pathology or condition which could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
  • Subject is
  • unsuccessful outcome from previous ALA-PDT therapy
  • currently enrolled in an drug or device study
  • has received an investigational drug or been treated with an investigational device within 30 days prior to the initiation of treatment
  • known sensitivity to one or more of the vehicle components (ethyl alcohol, isopropyl alcohol, laureth 4, polyethylene glycol)
  • use of the following topical preparations on the extremity to be treated:

    • Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days of initiation of treatment.
    • Cryotherapy within 2 weeks of initiation of treatment
    • Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks of initiation of treatment.
    • Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, ingenol mebutate, imiquimod or other topical treatments for AK within 8 weeks of initiation of treatment.
  • use of systemic retinoid therapy within 6 months of initiation of treatment.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
269 participants (actual)

Study arms

  • Experimental
    ALA

    Drug: Aminolevulinic Acid (ALA) · Device: Blue Light Photodynamic Therapy Illuminator (BLU-U)

  • Placebo comparator
    Vehicle

    Drug: Topical Solution Vehicle · Device: Blue Light Photodynamic Therapy Illuminator (BLU-U)

Interventions

  • 20% ALA applied to upper extremities for 3 hours prior to 10 J/cm2 blue light

    Also known as: Levulan Kerastick

  • DrugTopical Solution Vehicle

    Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to upper extremities 3 hours prior to 10 J/cm2 blue light

  • DeviceBlue Light Photodynamic Therapy Illuminator (BLU-U)

    10 J/cm2 blue light delivered at 10mW/cm2

06

What researchers measure

Primary outcomes

  1. Complete Clearance Rate

    proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 12

Secondary outcomes

  1. AK Clearance Rate

    {1 - \[(number of AK lesions at follow-up)/(number of AK lesions at Baseline)\]} x 100

    Time frame: Baseline and Week 12

  2. AK Clearance Rate

    {1 - \[(number of AK lesions at follow-up)/(number of AK lesions at Baseline)\]} x 100

    Time frame: Baseline and Week 8

  3. Complete Clearance Rate

    proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 8

  4. Subject Satisfaction Score

    Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)

    Time frame: Week 12

Other outcomes

  1. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Baseline

  2. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 24-48 hours after PDT #1

  3. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 2 Weeks after PDT #1

  4. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 4 Weeks after PDT #1

  5. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 8 Weeks after PDT #1

  6. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 12 Weeks after PDT #1

  7. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Baseline

  8. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 24-48 hours after PDT #1

  9. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 2 Weeks after PDT #1

  10. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 4 Weeks after PDT #1

  11. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 8 Weeks after PDT #1

  12. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 12 Weeks after PDT #1

  13. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Baseline

  14. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 5 minutes after PDT #1

  15. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 24-48 hours after PDT #1

  16. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 2 Weeks after PDT #1

  17. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 4 Weeks after PDT #1

  18. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 8 Weeks after PDT #1

  19. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 12 Weeks after PDT #1

  20. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Baseline

  21. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 5 minutes after PDT #1

  22. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 24-48 hours after PDT #1

  23. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 2 weeks after PDT #1

  24. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 4 Weeks after PDT #1

  25. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 8 Weeks after PDT #1

  26. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 12 Weeks after PDT #1

  27. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: Baseline

  28. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: During PDT #1

  29. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 5 minutes after PDT #1

  30. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 24-48 Hours after PDT #1

  31. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 2 Weeks after PDT #1

  32. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 4 Weeks after PDT #1

  33. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 8 Weeks after PDT #1

  34. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 12 Weeks after PDT #1

  35. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Baseline

  36. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 24-48 hours after PDT #1

  37. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 2 Weeks after PDT #1

  38. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 4 Weeks after PDT #1

  39. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 8 Weeks after PDT #1

  40. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 12 Weeks after PDT #1

  41. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Baseline

  42. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 24-48 hours after PDT #1

  43. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 2 Weeks after PDT #1

  44. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 4 Weeks after PDT #1

  45. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 8 Weeks after PDT #1

  46. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 12 Weeks after PDT #1

07

Results

Posted Sep 16, 2015

Participant flow

Participant flow — Overall Study
MilestoneALA-PDTVehicle
Started135134
Completed132130
Not completed34
Withdrew: Lost to follow-up10
Withdrew: Withdrawal by subject14
Withdrew: Subject moved out of state10

Outcome measures

PrimaryComplete Clearance Rate

proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 12
Reported as:
Number · participants
Complete Clearance Rate
participantsALA-PDTVehicle
Complete Clearance Rate4217
Statistical analysis
  • ALA-PDT vs Vehicle · Cochran-Mantel-Haenszel · p = 0.0001 (Analysis uses observed data only. Missing data was not imputed except for subjects with missing CCR are classified as not having a CCR (ie non-responder).)CMH test stratified by analysis center
SecondaryAK Clearance Rate

{1 - \[(number of AK lesions at follow-up)/(number of AK lesions at Baseline)\]} x 100

Time frame:
Baseline and Week 12
Reported as:
Mean · percentage of baseline lesions cleared
AK Clearance Rate
percentage of baseline lesions clearedALA-PDTVehicle
AK Clearance Rate69.1 ± 37.429.9 ± 51.5
Statistical analysis
  • ALA-PDT vs Vehicle · Mixed Models Analysis · p = <0.0001linear mixed model with fixed effects for treatment group, time point, and treatment group by time point interaction
SecondaryAK Clearance Rate

{1 - \[(number of AK lesions at follow-up)/(number of AK lesions at Baseline)\]} x 100

Time frame:
Baseline and Week 8
Reported as:
Mean · percentage of baseline lesions cleared
AK Clearance Rate
percentage of baseline lesions clearedALA-PDTVehicle
AK Clearance Rate53.4 ± 45.026.3 ± 44.3
Statistical analysis
  • ALA-PDT vs Vehicle · Mixed Models Analysis · p = <0.0001linear mixed model with fixed effects for treatment group, time point, and treatment group by time point interaction
SecondaryComplete Clearance Rate

proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 8
Reported as:
Number · participants
Complete Clearance Rate
participantsALA-PDTVehicle
Complete Clearance Rate3512
Statistical analysis
  • ALA-PDT vs Vehicle · Cochran-Mantel-Haenszel · p = 0.0001 (Analysis uses observed data only. Missing data was not imputed except for subjects with missing CCR are classified as not having a CCR (ie non-responder).)CMH test stratified by analysis center
SecondarySubject Satisfaction Score

Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)

Time frame:
Week 12
Reported as:
Number · participants
Subject Satisfaction Score
participantsALA-PDTVehicle
Very Satisfied7129
Moderately Satisfied4726
Slightly Satisfied1228
Not Satisfied448
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)4653
Grade 1 (light)5134
Grade 2 (moderate - small)2735
Grade 3 (moderate - moderate)1010
Grade 4 (marked)12
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)4658
Grade 1 (light)4934
Grade 2 (moderate - small)2830
Grade 3 (moderate - moderate)1110
Grade 4 (marked)12
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
2 Weeks after PDT #1
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)4558
Grade 1 (light)4635
Grade 2 (moderate - small)3330
Grade 3 (moderate - moderate)109
Grade 4 (marked)12
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)5156
Grade 1 (light)4437
Grade 2 (moderate - small)3028
Grade 3 (moderate - moderate)99
Grade 4 (marked)12
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)5153
Grade 1 (light)4437
Grade 2 (moderate - small)2727
Grade 3 (moderate - moderate)910
Grade 4 (marked)12
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Hyperpigmentation
participantsALA-PDTVehicle
Grade 0 (none)5249
Grade 1 (light)4243
Grade 2 (moderate - small)2926
Grade 3 (moderate - moderate)810
Grade 4 (marked)12
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7564
Grade 1 (light)4047
Grade 2 (moderate - small)1617
Grade 3 (moderate - moderate)44
Grade 4 (marked)02
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7668
Grade 1 (light)4246
Grade 2 (moderate - small)1214
Grade 3 (moderate - moderate)54
Grade 4 (marked)02
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
2 Weeks after PDT #1
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7467
Grade 1 (light)4447
Grade 2 (moderate - small)1314
Grade 3 (moderate - moderate)44
Grade 4 (marked)02
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7665
Grade 1 (light)4247
Grade 2 (moderate - small)1314
Grade 3 (moderate - moderate)44
Grade 4 (marked)02
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7563
Grade 1 (light)3945
Grade 2 (moderate - small)1515
Grade 3 (moderate - moderate)34
Grade 4 (marked)02
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Hypopigmentation
participantsALA-PDTVehicle
Grade 0 (none)7366
Grade 1 (light)4045
Grade 2 (moderate - small)1614
Grade 3 (moderate - moderate)33
Grade 4 (marked)02
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Baseline
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)7373
Grade 1 (minimal)3839
Grade 2 (mild)2119
Grade 3 (moderate)33
Grade 4 (severe)00
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
5 minutes after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)1257
Grade 1 (light)2641
Grade 2 (mild)4327
Grade 3 (moderate)529
Grade 4 (severe)20
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)264
Grade 1 (minimal)1643
Grade 2 (mild)4823
Grade 3 (moderate)664
Grade 4 (severe)30
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
2 Weeks after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)2861
Grade 1 (minimal)4658
Grade 2 (mild)5114
Grade 3 (moderate)101
Grade 4 (severe)00
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)5472
Grade 1 (minimal)5449
Grade 2 (mild)2411
Grade 3 (moderate)30
Grade 4 (severe)00
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)7981
Grade 1 (minimal)3039
Grade 2 (mild)187
Grade 3 (moderate)52
Grade 4 (severe)00
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Erythema
participantsALA-PDTVehicle
Grade 0 (none)8085
Grade 1 (minimal)3436
Grade 2 (mild)158
Grade 3 (moderate)31
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Baseline
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)133134
Grade 1 (minimal)20
Grade 2 (mild)00
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
5 minutes after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)92127
Grade 1 (minimal)307
Grade 2 (mild)100
Grade 3 (moderate)30
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)89133
Grade 1 (minimal)270
Grade 2 (mild)181
Grade 3 (moderate)10
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
2 weeks after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)131134
Grade 1 (minimal)40
Grade 2 (mild)00
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)134132
Grade 1 (minimal)10
Grade 2 (mild)00
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)131128
Grade 1 (minimal)00
Grade 2 (mild)10
Grade 3 (moderate)01
Grade 4 (severe)00
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Edema
participantsALA-PDTVehicle
Grade 0 (none)132130
Grade 1 (minimal)00
Grade 2 (mild)00
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
Baseline
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)134133
Grade 1 (mild)10
Grade 2 (moderate)01
Grade 3 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
During PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)10111
Grade 1 (mild)3923
Grade 2 (moderate)740
Grade 3 (severe)120
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
5 minutes after PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)30130
Grade 1 (mild)704
Grade 2 (moderate)350
Grade 3 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
24-48 Hours after PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)107132
Grade 1 (mild)232
Grade 2 (moderate)50
Grade 3 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
2 Weeks after PDT #1
Reported as:
Number · ITT
Stinging/Burning
ITTALA-PDTVehicle
Grade 0 (none)131134
Grade 1 (mild)30
Grade 2 (moderate)00
Grade 3 (severe)10
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)132132
Grade 1 (mild)20
Grade 2 (moderate)10
Grade 3 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)130129
Grade 1 (mild)20
Grade 2 (moderate)00
Grade 3 (severe)00
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Stinging/Burning
participantsALA-PDTVehicle
Grade 0 (none)130130
Grade 1 (mild)10
Grade 2 (moderate)10
Grade 3 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Baseline
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)8378
Grade 1 (minimal)3541
Grade 2 (mild)1011
Grade 3 (moderate)74
Grade 4 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)8479
Grade 1 (minimal)3040
Grade 2 (mild)1710
Grade 3 (moderate)45
Grade 4 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
2 Weeks after PDT #1
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)3381
Grade 1 (minimal)4738
Grade 2 (mild)2911
Grade 3 (moderate)264
Grade 4 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)7383
Grade 1 (minimal)4438
Grade 2 (mild)1511
Grade 3 (moderate)30
Grade 4 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)8386
Grade 1 (minimal)3535
Grade 2 (mild)115
Grade 3 (moderate)33
Grade 4 (severe)00
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Scaling & Dryness
participantsALA-PDTVehicle
Grade 0 (none)8586
Grade 1 (minimal)3332
Grade 2 (mild)910
Grade 3 (moderate)52
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Baseline
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)128129
Grade 1 (minimal)74
Grade 2 (mild)01
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)116127
Grade 1 (minimal)123
Grade 2 (mild)53
Grade 3 (moderate)21
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
2 Weeks after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)92129
Grade 1 (minimal)234
Grade 2 (mild)161
Grade 3 (moderate)40
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
4 Weeks after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)121129
Grade 1 (minimal)122
Grade 2 (mild)21
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
8 Weeks after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)125124
Grade 1 (minimal)53
Grade 2 (mild)22
Grade 3 (moderate)00
Grade 4 (severe)00
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
12 Weeks after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting
participantsALA-PDTVehicle
Grade 0 (none)123125
Grade 1 (minimal)54
Grade 2 (mild)30
Grade 3 (moderate)11
Grade 4 (severe)00

Adverse events

Collected over 3 months. Non-serious events are listed at a 3% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ALA-PDT—5/135 (3.7%)6/135 (4.4%)
Vehicle—2/134 (1.5%)6/134 (4.5%)
Most frequent serious events
Showing 10 of 11
Most frequent serious events
EventALA-PDTVehicle
DyspnoeaRespiratory, thoracic and mediastinal disorders2/1350/134
Iron Deficiency AnaemiaBlood and lymphatic system disorders0/1351/134
PancreatitisGastrointestinal disorders0/1351/134
Angina UnstableCardiac disorders1/1350/134
Atrial FibrillationCardiac disorders1/1350/134
Chest PressureCardiac disorders1/1350/134
AppendicitisInfections and infestations1/1350/134
DizzinessNervous system disorders1/1350/134
SyncopeNervous system disorders1/1350/134
Renal Failure AcuteRenal and urinary disorders1/1350/134
Most frequent other events
Most frequent other events
EventALA-PDTVehicle
NasopharyngitisInfections and infestations2/1354/134
Squamous Cell Carcinoma of SkinNeoplasms benign, malignant and unspecified (incl cysts and polyps)4/1352/134

Baseline characteristics

ITT

Age, Continuous
Age, Continuous(years)ALA-PDTVehicleTotal
Mean67.6 (45 to 90)67.6 (47 to 87)67.6 (45 to 90)
Sex: Female, Male
Sex: Female, Male(Participants)ALA-PDTVehicleTotal
Female433881
Male9296188
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)ALA-PDTVehicleTotal
Hispanic or Latino033
Not Hispanic or Latino135131266
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)ALA-PDTVehicleTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White135134269
More than one race000
Unknown or Not Reported000
Skin Type
Skin Type(participants)ALA-PDTVehicleTotal
Type I171633
Type II6773140
Type III373269
Type IV141327
Type V000
Type VI000
Total Number AK Lesions (Grade 1/2)
Total Number AK Lesions (Grade 1/2)(lesions per subject)ALA-PDTVehicleTotal
Mean8.5 ± 3.68.6 ± 3.48.5 ± 3.5
08

Study locations

13 sites
  • Center For Dermatology Clinical Research, Inc.
    Fremont, California 94538, United States
  • UCSD Dermatology
    San Diego, California 92122, United States
  • Center for Clinical and Cosmetic Research
    Aventura, Florida 33180, United States
  • MOORE Clinical Research, Inc
    Brandon, Florida 33609, United States
  • Spencer Clinical Services
    St. Petersburg, Florida 33716, United States
  • Altman Dermatology Associates
    Arlington Heights, Illinois 60005, United States
  • Shideler Clinical Research Center
    Carmel, Indiana 46032, United States
  • The Indiana Clinical Trials Center, PC
    Plainfield, Indiana 46168, United States
  • Minnesota Clinical Study Center
    Fridley, Minnesota 55432, United States
  • Oregon Dermatology and Research Center
    Portland, Oregon 97210, United States
  • J&S Studies, Inc
    College Station, Texas 77845, United States
  • Suzanne Bruce and Associates, P.A.,The Center for Skin Research
    Houston, Texas 77056, United States
  • Virginia Clinical Research, Inc.
    Norfolk, Virginia 23507, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2014, a primary completion of Mar 2015 and a completion of Mar 2015. It does not say whether these dates are actual or estimated.

Results were first posted in Sep 2015, 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2014
First posted
May 14, 2014
Start
May 2014
Primary completionActual
Mar 2015
CompletionActual
Mar 2015
Results first posted
Sep 16, 2015
Last update
Sep 16, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02137785
Responsible party
Sponsor
First posted
May 14, 2014
Start date
May 2014
Primary completion
Mar 2015
Completion
Mar 2015
Results posted
Sep 16, 2015
Last update
Sep 16, 2015

Study contacts

Stuart Marcus, MD, PhD
study director · DUSA Pharmaceuticals, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Aminolevulinic Acid

Start the discussion